双重膜滤过式血浆置换清除肾移植受者供体特异性抗体的临床观察

Clinical observation on the removal of donor specific antibody by double filtration plasmapheresis in renal transplant recipients

    摘要
  • 摘要:
      目的  探讨双重膜滤过式血浆置换（DFPP）对高致敏肾移植受者的供体特异性抗体（DSA）的清除效果。
      方法  4例肾移植高致敏受者共进行了7例次DFPP治疗，采用Luminex技术监测DSA的变化，观察治疗效果、急性排斥反应发生情况及其不良反应。
      结果  治疗后DSA的MFI 1 036（0~4 113）较治疗前6 446（2 999~12 905）明显下降（Z=-2.503，P=0.012）。4例高致敏肾移植受者均未发生超急性排斥反应，仅有1例发生急性排斥反应且通过术后DFPP治疗及调整免疫抑制剂得到逆转。受者随访至今移植肾功能良好，未发生排斥反应。DFPP治疗引起白蛋白水平下降。
      结论  DFPP可以有效清除受者体内的DSA，可以安全、有效地预防高致敏人群肾移植术后急性排斥反应。

     

    Abstract:
      Objective  To investigate the effect of double filtration plasmapheresis (DFPP) upon the removal of donor specific antibody (DSA) in highly sensitized recipients with renal transplantation.
      Methods  Four highly sensitized recipients undergoing renal transplantation received 7 cycles of DFPP. Luminex technology was adopted to monitor the changes of DSA. Clinical efficacy, incidence of acute rejection and adverse reactions were observed.
      Results  After DFPP, the DSA MFI 1 036 (0-4 113) was significantly declined than that before treatment 6 446 (2 999-12 905), Z=-2.503, P=0.012. No hyperacute rejections occurred in four highly sensitized recipients undergoing renal transplantation. Acute rejection was noted in one case, which was mitigated by postoperative DFPP and adjustment of immunosuppressive agents. During postoperative follow-up, the function of transplant kidney was normal and no rejection reactions occurred. The level of albumin was decreased after DFPP.
      Conclusions  DFPP can effectively remove the DSA in the recipients. It is an efficacious and safe approach to prevent the incidence of acute rejections in highly sensitized recipients after renal transplantation.

     

    • HTML全文
    • 参考文献(15)
    • 相关文章
    • 施引文献
  • 资源附件(0)

/

返回文章
返回